|
|
Gene Symbol |
CYP11B2 |
|
Aliases |
ALDOS, CPN2, CYP11B, CYP11BL, CYPXIB2, P-450C18, P450C18, P450aldo |
|
Entrez Gene ID |
|
|
Gene Name |
Cytochrome P450 family 11 subfamily B member 2 |
|
Chromosomal Location |
8q24.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane. The enzyme has steroid 18-hydroxylase activity to synthesize aldosterone and 18-oxocortisol as well as steroid 11 beta-hydroxylase activity. Mutations in this gene cause corticosterone methyl oxidase deficiency. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Cytochrome P450 11B2, mitochondrial, aldosterone synthase, aldosterone-synthesizing enzyme, corticosterone 18-monooxygenase, CYP11B2, cytochrome P-450Aldo, cytochrome P-450C18, cytochrome P450, family 11, subfamily B, polypeptide 2, cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 2, mitochondrial cytochrome P450, family 11, subfamily B, polypeptide 2, steroid 11-beta-hydroxylase, CYP11B2, steroid 11-beta-monooxygenase, steroid 11-beta/18-hydroxylase, steroid 18-hydroxylase, aldosterone synthase, P450C18, P450aldo |
|
Function |
A cytochrome P450 monooxygenase that catalyzes the biosynthesis of adrenal mineralocorticoid aldosterone. Catalyzes three sequential oxidative reactions of 11-deoxycorticosterone/21-hydroxyprogesterone, namely 11-beta hydroxylation followed with two successive oxidations at C18 to yield 18-hydroxy and then 18-aldehyde derivatives, resulting in the formation of aldosterone. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin) |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00067 |
p450 |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000419970 |
P16435 |
P16435 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
Corticosterone Methyl Oxidase Deficiency |
|
Hypoaldosteronism |
|
Hyperaldosteronism |
|
Conn Syndrome |
|
PCOS |
|
Neoplasms |
Prostate cancer |
|
Reproductive disorders |
Preeclampsia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
PCOS |
(T-->C) of -344T polymorphism |
|
Direct
|
92 women with PCOS and 92 controls |
The variants (T-->C) of -344T polymorphism site of CYP11B2 gene predisposes increased risk ofPCOS. |
|
|
|
|